Since sphingosine can be further converted into S1P, which promotes cell survival, targeting AC has emerged as a potential therapeutic strategy to inhibit cancer cell proliferation through the Akt or MAPK pathways and induce apoptosis by ceramide accumulation [41]. Here, AKT1 is linked to cancer.